SCHEMBL776935

SCHEMBL776935

O=S(OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
EPHX2 P34913 1/20 0.48
IDO1 P14902 1/20 0.48
AGXT P21549 1/20 0.46
ALDH1A1 P00352 4/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 2/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PDPK1 O15530 1/20 0.41
MTOR P42345 1/20 0.41
PARP10 Q53GL7 1/20 0.41
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342737 0.89 TSHR (0.43) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL4344980 0.87 TSHR (0.44) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL10692407 0.87 TSHR (0.44) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL7698932 0.86 TSHR (0.41) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL28652165 0.85 TSHR (0.43) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL9066394 0.84 ALOX15 (0.45) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL7703223 0.83 ALDH1A1 (0.49) TSHREPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL11661662 0.82 TSHR (0.40) TSHREPHX2IDO1AGXTALDH1A1
SCHEMBL7700814 0.82 EPHX2 (0.46) TSHREPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL3704561 0.81 TSHR (0.48) TSHREPHX2IDO1AGXTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403256-B1 Alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfite additive WILSON GREATBATCH LTD. 2002-06-11 US claimed
US-6350542-B1 Sulfite additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. 2002-02-26 US claimed
EP-1022799-A2 Sulfite additives for non-aqueous electrolyte rechargeable cells Wilson Greatbatch Limited (US) 2000-07-26 EP claimed
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2026-05-28 US disclosed
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2025-07-10 US disclosed
US-20250213436-A1 POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2025-07-03 US disclosed
EP-4548901-A1 CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED ARTICLE, AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2025-05-07 EP disclosed
EP-4548902-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2025-05-07 EP disclosed
WO-2025062848-A1 ASCORBIC ACID DERIVATIVE, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, KIT FOR PREPARING CURABLE COMPOSITION, CURABLE COMPOSITION, CURED OBJECT, AND DENTAL MATERIAL 三井化学株式会社 2025-03-27 WO disclosed
EP-4501974-A1 POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, KIT FOR PREPARING CURABLE COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2025-02-05 EP disclosed
EP-4484421-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR INITIATING POLYMERIZATION, POLYMERIZATION INITIATOR, KIT FOR PREPARING CURABLE COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2025-01-01 EP disclosed
US-6670078-B1 Having current collector for positive electrode and portion of outer can contacting electrolytic solution at side of positive electrode made of valve metal or alloy thereof; excellent in low temperature characteristics and long-term stability MITSUBISHI CHEMICAL CORPORATION (JP) 2003-12-30 US disclosed
US-20030109387-A1 Peak torque lowering composition, part with sliding part using the composition, and press-fitting method using the composition CITIZEN WATCH CO., LTD. (JP) 2003-06-12 US disclosed
US-6403256-B1 Alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfite additive WILSON GREATBATCH LTD. 2002-06-11 US disclosed
US-6350542-B1 Sulfite additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. 2002-02-26 US disclosed
CN-1278953-A Nonaqueous electrolyte battery MITSUBISHI CHEM CORP (JP) 2001-01-03 CN disclosed
EP-1030399-A1 NON-AQUEOUS ELECTROLYTE CELL MITSUBISHI CHEMICAL CORPORATION (JP) 2000-08-23 EP disclosed
EP-1022799-A3 Sulfite additives for non-aqueous electrolyte rechargeable cells Wilson Greatbatch Limited (US) 2000-08-02 EP disclosed
EP-1022799-A2 Sulfite additives for non-aqueous electrolyte rechargeable cells Wilson Greatbatch Limited (US) 2000-07-26 EP disclosed
EP-1022799-A2 Sulfite additives for non-aqueous electrolyte rechargeable cells Wilson Greatbatch Limited (US) 2000-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL PROC, THEM6, RBCK1 TSHR 4865/4885EPHX2 869/4885IDO1 4604/4885
US-20250213436-A1 POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL DNMT3L, CDK9, CDK6 TSHR 4748/4885EPHX2 2187/4885IDO1 4500/4885
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL CAD, KIT, ILK TSHR 4509/4885EPHX2 717/4885IDO1 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.